Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars-Gunnar Larsson

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Nature Cell Biology|February 22, 2005
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcriptionAzadeh Arabi, Siqin Wu, Karin Ridderstråle, et al.
The Journal of Biological Chemistry|June 22, 2014
Sin3b interacts with Myc and decreases Myc levelsPablo Garcia-Sanz, Andrea Quintanilla, M Carmen Lafita, et al.
Elife|July 7, 2020
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancerAndrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson, et al.
Oncotarget|December 25, 2015
Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradationFuad Bahram, Per Hydbring, Susanna Tronnersjö, et al.
Nature Cell Biology|December 17, 2009
Cdk2 suppresses cellular senescence induced by the c-myc oncogeneStefano Campaner, Mirko Doni, Per Hydbring, et al.
Nature Communications|September 6, 2022
HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infectionRuining Liu, Victoria Muliadi, Wenjun Mou, et al.
Molecular Cell|May 29, 2003
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcriptionNatalie von der Lehr, Sara Johansson, Siqin Wu, et al.
Plos One|January 30, 2010
Myc is required for activation of the ATM-dependent checkpoints in response to DNA damageLina Guerra, Ami Albihn, Susanna Tronnersjö, et al.
Nature Communications|November 2, 2022
Publisher Correction: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infectionRuining Liu, Victoria Muliadi, Wenjun Mou, et al.
Oncoimmunology|April 30, 2026
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8<sup><b>+</b></sup> T cellsJeroen Melief, Lucas Baldran-Groves, Marc-Antoine Gerault, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Nature Cell Biology|February 22, 2005
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcriptionAzadeh Arabi, Siqin Wu, Karin Ridderstråle, et al.
The Journal of Biological Chemistry|June 22, 2014
Sin3b interacts with Myc and decreases Myc levelsPablo Garcia-Sanz, Andrea Quintanilla, M Carmen Lafita, et al.
Elife|July 7, 2020
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancerAndrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson, et al.
Oncotarget|December 25, 2015
Interferon-γ-induced p27KIP1 binds to and targets MYC for proteasome-mediated degradationFuad Bahram, Per Hydbring, Susanna Tronnersjö, et al.
Nature Cell Biology|December 17, 2009
Cdk2 suppresses cellular senescence induced by the c-myc oncogeneStefano Campaner, Mirko Doni, Per Hydbring, et al.
Nature Communications|September 6, 2022
HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infectionRuining Liu, Victoria Muliadi, Wenjun Mou, et al.
Molecular Cell|May 29, 2003
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcriptionNatalie von der Lehr, Sara Johansson, Siqin Wu, et al.
Plos One|January 30, 2010
Myc is required for activation of the ATM-dependent checkpoints in response to DNA damageLina Guerra, Ami Albihn, Susanna Tronnersjö, et al.
Nature Communications|November 2, 2022
Publisher Correction: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infectionRuining Liu, Victoria Muliadi, Wenjun Mou, et al.
Oncoimmunology|April 30, 2026
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8<sup><b>+</b></sup> T cellsJeroen Melief, Lucas Baldran-Groves, Marc-Antoine Gerault, et al.
Pageof 7